Q -- HRSA 340B Prime Vendor Agreement

The contract extends the HRSA 340B Prime Vendor Agreement for an additional year, covering the period from September 10, 2007, through September 9, 2008, under the exercise of Option Year Two. Health Purchasing Partners International, the designated 340B Prime Vendor, has successfully supported 340B safety-net hospitals and clinics by negotiating favorable pricing for more than 2,600 brand and generic drugs, achieving discounts ranging from 1 to 90 percent below the statutory 340B ceiling price, with an average savings of 17 percent. The vendor has also secured agreements with 12 national and regional drug distributors, including specialty wholesalers, resulting in an average 7 percent reduction in distribution costs, a key benefit especially for smaller clinics. In addition to drug pricing and distribution savings, the contract emphasizes value-added services, such as negotiating access to vaccines, diabetic testing supplies, and rapid HIV test kits, thereby broadening the scope of essential products available to participating entities. This extension is part of a five-year agreement initially effective in 2004 and highlights the ongoing efforts to enhance cost efficiency and improve healthcare resources for safety-net providers under the HRSA 340B program. The contract remains a non-solicitation announcement, with the contracting officer listed as Francis R Murphy.